|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Conlon MS, Johnson KC, Bewick MA, Lafrenie
RM and Donner A: Smoking (active and passive), N-acetyltransferase
2, and risk of breast cancer. Cancer Epidemiol. 34:142–149. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Beasley JM, Coronado GD, Livaudais J, et
al: Alcohol and risk of breast cancer in Mexican women. Cancer
Causes Control. 21:863–870. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thorel F, Constantinou A, Dunand-Sauthier
I, et al: Definition of a short region of XPG necessary for TFIIH
interaction and stable recruitment to sites of UV damage. Mol Cell
Biol. 24:10670–10680. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Collins A and Harrington V: Repair of
oxidative DNA damage: assessing its contribution to cancer
prevention. Mutagenesis. 17:489–493. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berwick M and Vineis P: Markers of DNA
repair and susceptibility to cancer in humans: an epidemiologic
review. J Natl Cancer Inst. 92:874–897. 2000. View Article : Google Scholar
|
|
7
|
Kiyohara C and Yoshimasu K: Genetic
polymorphisms in the nucleotide excision repair pathway and lung
cancer risk: a meta-analysis. Int J Med Sci. 4:59–71. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sanyal S, Festa F, Sakano S, et al:
Polymorphisms in DNA repair and metabolic genes in bladder cancer.
Carcinogenesis. 25:729–734. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sobti RC, Berhane N, Mehedi SA, et al:
Association and impact of XPG Asp 1104 His gene polymorphism in HIV
1 disease progression to AIDS among north Indian HIV seropositive
individuals. Mol Biol Rep. 37:317–324. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kumar R, Hoglund L, Zhao C, Forsti A,
Snellman E and Hemminki K: Single nucleotide polymorphisms in the
XPG gene: determination of role in DNA repair and breast cancer
risk. Int J Cancer. 103:671–675. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Little J, Bradley L, Bray MS, et al:
Reporting, appraising, and integrating data on genotype prevalence
and gene-disease associations. Am J Epidemiol. 156:300–310. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lau J, Ioannidis JP and Schmid CH:
Quantitative synthesis in systematic reviews. Ann Intern Med.
127:820–826. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
15
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mechanic LE, Millikan RC, Player J, et al:
Polymorphisms in nucleotide excision repair genes, smoking and
breast cancer in African Americans and whites: a population-based
case-control study. Carcinogenesis. 27:1377–1385. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen J, Desai M, Agrawal M, et al:
Polymorphisms in nucleotide excision repair genes and DNA repair
capacity phenotype in sisters discordant for breast cancer. Cancer
Epidemiol Biomarkers Prev. 15:1614–1619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Crew KD, Gammon MD, Terry MB, et al:
Polymorphisms in nucleotide excision repair genes, polycyclic
aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer
Epidemiol Biomarkers Prev. 16:2033–2041. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jorgensen TJ, Visvanathan K, Ruczinski I,
Thuita L, Hoffman S and Helzlsouer KJ: Breast cancer risk is not
associated with polymorphic forms of xeroderma pigmentosum genes in
a cohort of women from Washington County, Maryland. Breast Cancer
Res Treat. 101:65–71. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rajaraman P, Bhatti P, Doody MM, et al:
Nucleotide excision repair polymorphisms may modify ionizing
radiation-related breast cancer risk in US radiologic
technologists. Int J Cancer. 123:2713–2716. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smith TR, Levine EA, Freimanis RI, et al:
Polygenic model of DNA repair genetic polymorphisms in human breast
cancer risk. Carcinogenesis. 29:2132–2138. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ming-Shiean H, Yu JC, Wang HW, et al:
Synergistic effects of polymorphisms in DNA repair genes and
endogenous estrogen exposure on female breast cancer risk. Ann Surg
Oncol. 17:760–771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Harrington JJ and Lieber MR: Functional
domains within FEN-1 and RAD2 define a family of structure-specific
endonucleases: implications for nucleotide excision repair. Genes
Dev. 8:1344–1355. 1994. View Article : Google Scholar
|
|
24
|
Matsunaga T, Park CH, Bessho T, Mu D and
Sancar A: Replication protein A confers structure-specific
endonuclease activities to the XPF-ERCC1 and XPG subunits of human
DNA repair excision nuclease. J Biol Chem. 271:11047–11050. 1996.
View Article : Google Scholar
|
|
25
|
Bessho T: Nucleotide excision repair 3′
endonuclease XPG stimulates the activity of base excision repair
enzyme thymine glycol DNA glycosylase. Nucleic Acids Res.
27:979–983. 1999.
|
|
26
|
Fagbemi AF, Orelli B and Scharer OD:
Regulation of endonuclease activity in human nucleotide excision
repair. DNA Repair (Amst). 10:722–729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang JS, Wrensch MR, Hansen HM, et al:
Nucleotide excision repair genes and risk of lung cancer among San
Francisco Bay Area Latinos and African Americans. Int J Cancer.
123:2095–2104. 2008. View Article : Google Scholar
|
|
28
|
Biason P, Hattinger CM, Innocenti F, et
al: Nucleotide excision repair gene variants and association with
survival in osteosarcoma patients treated with neoadjuvant
chemotherapy. Pharmacogenomics J. 12:476–483. 2012. View Article : Google Scholar : PubMed/NCBI
|
